4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-25-101314
President and CEO sold 16,775 shares at an average $40.37 ($677,198)
- President and CEO acquired 50,000 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2025-10-17 | Sale 10b5-1 | −700 | $40.03 | $28,022 | 39,974 | I |
| BENDHEIM JACK President and CEO | 2025-10-20 | Sale 10b5-1 | −16,075 | $40.38 | $649,176 | 23,899 | I |
| BENDHEIM JACK President and CEO | 2025-10-21 | Conversion 10b5-1 | +50,000 | 73,899 | I | ||
| Derivatives | |||||||
| BENDHEIM JACK President and CEO | 2025-10-21 | Conversion · Class B Common Stock 10b5-1 | −50,000 | 20,086,034 | I | ||
| Open-market sales · 16,775 sh · avg $40.37 · $677,198 | |||||||
Loading xslF345X05/tm2529035-1_4seq1.xml…